Starting Dose (Weeks 1-4): 2 mg Every patient begins at 2 mg once weekly, regardless of target maintenance dose
At the conclusion of the three studies, results were reported as follows: Average weight loss: 5.9% of starting weight among 3,122 participants across three studies
*Disclaimer: The FDA-approved brand name drugs, such as Wegovy, and Ozempic are manufactured by the Novo Nordisk company
En esa lnea, el mdico aclar que aunque podra provocar una pancreatitis, que sera un cuadro agudo, las probabilidades son muy pocas de que eso suceda.
In almost all cases, sermorelin therapy will be avoided during pregnancy and lactation to err on the side of caution, unless there are special circumstances and a consensus that treatment is necessary